165
Views
12
CrossRef citations to date
0
Altmetric
Research Articles

Stimuli-responsive/smart tablet formulations (under simulated physiological conditions) for oral drug delivery system based on glucuronoxylan polysaccharide

, , , , &
Pages 122-134 | Received 21 Jul 2019, Accepted 14 Dec 2019, Published online: 06 Jan 2020
 

Abstract

Objective: Development of stimuli-responsive intelligent drug delivery system (based on a polysaccharide, glucuronoxylan [GX]) with on-off switching properties under physiological conditions.

Significance: As GX exhibits high swelling index and stimuli-responsive swelling/de-swelling properties, therefore, this material appeared highly useful to design pH, solvent and ionic stress-sensitive oral tablet formulations, which offered on-off switching properties. In this way, we could design intelligent/smart drug delivery systems for levosulpiride (LS) and theophylline (TF) with valuable pharmaceutical properties.

Methods: GX-based tablet formulations were explored for stimuli-responsive, reversible swelling–deswelling behavior, dynamic swelling, and its kinetics. Tablet surface and channeling after swelling were observed using scanning electron microscopy (SEM). Drug release study was performed mimicking the physiological conditions like pH and transit time of gastrointestinal tract (GIT). Radiographic images of tablet path (in vivo) were recorded.

Results: GX-based formulations exhibited high swelling in deionized water (DW), pH 6.8 and 7.4 while negligible swelling at pH 1.2. SEM images discovered the presence of microcracks and nanopores on the surface of tablets and showed channeling after swelling of tablets in DW. Sustained drug release was observed and found directly proportional to the concentration of GX in the formulations with negligible release at pH 1.2. In vivo radiographic evaluation indicated the retention of tablets in GIT for 7 h. Hemocompatibility studies showed the non-thrombogenic and non-hemolytic nature of GX.

Conclusions: GX-based smart/stimuli-responsive formulations can control/sustain the release of drugs in GIT.

Acknowledgments

G. Muhammad gratefully acknowledges the Higher Education Commission, Pakistan for funding under “HEC Indigenous 5000 Fellowships” scheme. We are grateful to Consolidated Chemical Laboratories (Pvt.) Ltd. for generously gifting the levosulpiride; Instruments Labs, University of Sargodha for extensive utilization of instruments; Prof. Dr. Irshad Hussain and Mr. Zajif Hussain for acquisition of SEM and X-ray technician and radiographer, and Mubarak Medical Complex, Sargodha, Pakistan for technical help and provision of X-ray facility.

Disclosure statement

The authors report no declaration of interest.

Additional information

Funding

This study was supported by the Higher Education Commission, Pakistan under “HEC Indigenous 5000 Fellowships” scheme.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.